BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 359982)

  • 1. [Therapy using immunosuppressive agents following clinical transplantation of bone marrow].
    Silobrcić V
    Lijec Vjesn; 1978 Jun; 100(6):394-5. PubMed ID: 359982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunologic problems of bone marrow transplantation].
    Faĭnshteĭn FE; Zotikov EA
    Probl Gematol Pereliv Krovi; 1966 Feb; 11(2):3-6. PubMed ID: 4863867
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of donor bone marrow on survival of composite tissue allografts.
    Siemionow M; Nasir S
    Ann Plast Surg; 2008 Apr; 60(4):455-62. PubMed ID: 18362579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow transplantation. 1. Treatment of medullary aplasias].
    Perreault C; Boileau J; Bonny Y; d'Angelo G; Gyger M; Lacombe M; Lavallée R
    Union Med Can; 1981 Mar; 110(3):264-8. PubMed ID: 7018046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allogeneic bone marrow transplantation].
    Gmür J
    Ther Umsch; 1988 Feb; 45(2):131-6. PubMed ID: 3282339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prerequisites for immunosuppressive therapy in primary aplastic leukemias].
    Brüster H
    Kinderarztl Prax; 1970 May; 38(5):193-8. PubMed ID: 4921795
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
    Adams GB; Lipton JH; Jamal N; Messner HA
    Bone Marrow Transplant; 1994 Jun; 13(6):831-3. PubMed ID: 7920323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
    Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.
    Helg C; Chapuis B; Bolle JF; Morel P; Salomon D; Roux E; Antonioli V; Jeannet M; Leski M
    Transplantation; 1994 Dec; 58(12):1420-2. PubMed ID: 7809937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic studies in the lymphocyte culture after high voltage radiotherapy or high-dosage cytostatic therapy and bone marrow transplantation].
    Stinner G; zur Horst-Meyer H
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:116-7. PubMed ID: 4990188
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation.
    Ramsay NK
    Trans Assoc Life Insur Med Dir Am; 1988; 71():162-73. PubMed ID: 3285567
    [No Abstract]   [Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome.
    Filipovich AH; Blazar BR; Ramsay NK; Kersey JH; Zelkowitz L; Harada S; Purtilo DT
    Transplantation; 1986 Aug; 42(2):222-4. PubMed ID: 3526660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone marrow transplantation. Recent progress and current indications].
    Jeannet M
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1581-3. PubMed ID: 4405058
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.
    Barber WH; Laskow DA; Deierhoi MH; Juilian BA; Curtis JJ; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1787-9. PubMed ID: 2652584
    [No Abstract]   [Full Text] [Related]  

  • 15. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with sandoglobulin in bone marrow transplantation.
    Tutschka PJ; Copelan EA
    Int J Cell Cloning; 1986; 4 Suppl 1():181-8. PubMed ID: 3018102
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome.
    Tamura K; Kanazawa T; Suzuki M; Koitabashi M; Ogawa C; Morikawa A
    Am J Hematol; 2006 Feb; 81(2):139-41. PubMed ID: 16432864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of severe acquired aplastic anemia].
    Jacobsen N
    Nord Med; 1995; 110(12):314-5. PubMed ID: 8524632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical use of immunosuppression].
    Amiel JL
    Munch Med Wochenschr; 1970 Mar; 112(12):497-500. PubMed ID: 4911634
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunodepression].
    Amiel JL
    Cah Med; 1970 May; 11(5):383-8. PubMed ID: 4912852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.